Panagesic (Nefopam Hydrochloride)

Nefopam hydrochloride, the active ingredient in Panagesic, is an analgesic presented as a tablet for oral use. It is employed to manage moderate pain in adult patients. GNH USA supplies Panagesic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Panagesic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Panagesic (nefopam hydrochloride) is used in the management of pain where non‑opioid analgesia is preferred.

- Post‑operative pain: provides analgesia without opioid‑related side effects. - Musculoskeletal pain: reduces discomfort associated with strains, sprains and low‑back pain. - Acute headache: alleviates tension‑type headache symptoms. - Cancer‑related pain: used as part of multimodal analgesia for breakthrough pain. - Chronic neuropathic pain: may contribute to pain control when combined with other agents. - Visceral pain: helps‑manage pain from abdominal or pelvic sources.

Adverse reactions to nefibul may vary in frequency and severity.

Common Side Effects: - Nausea and vomiting - Sweating (hyper‑hygrosis) - Dry‑mouth - Blurred blur blur  a - Dizziness  - Tachycard 

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Cardiac arrhythmias  - Seizure  - Low blood pressure - Hepatotoxic  y - Blood clot disorder  -  t t t

When   t t t  ewline   ewline  ewline  ewline

t  ewline  ewline 

ewline 

ewline ullet ullet ullet \

   ",